Similar articles

• Alpha-fetoprotein and hepatocellular carcinoma.

  Colli A, Fraquelli M, Conte D. Colli A, et al. Am J Gastroenterol. 2006 Aug;101(8):1939; author reply 1940-1. doi: 10.1111/j.1572-0241.2006.00684_3.x. Am J Gastroenterol. 2006. PMID: 16928257 No abstract available.
• [Measurement of alpha-fetoprotein with L3 fraction in the early diagnosis of patients with hepatocellular carcinoma].

  Aoyagi Y, Kubota T. Aoyagi Y, et al. Nihon Rinsho. 2005 Aug;63 Suppl 8:625-8. Nihon Rinsho. 2005. PMID: 16149595 Review. Japanese. No abstract available.
• [Measurement of alpha-fetoprotein with L3 fraction in the early diagnosis of patients with hepatocellular carcinoma].

  Aoyagi Y, Suda T, Kawai H, Tamura Y, Igarashi M. Aoyagi Y, et al. Nihon Rinsho. 2010 Jul;68 Suppl 7:665-9. Nihon Rinsho. 2010. PMID: 20960847 Japanese. No abstract available.
• Fucosylation index of alpha-fetoprotein, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis.

  Aoyagi Y, Saitoh A, Suzuki Y, Igarashi K, Oguro M, Yokota T, Mori S, Suda T, Isemura M, Asakura H. Aoyagi Y, et al. Hepatology. 1993 Jan;17(1):50-2. Hepatology. 1993. PMID: 7678576
• [Alpha-fetoprotein producing hepatocellular carcinoma, AT-III producing hepatocellular carcinoma].

  Nakamura K, Makino I. Nakamura K, et al. Ryoikibetsu Shokogun Shirizu. 1995;(7):265-8. Ryoikibetsu Shokogun Shirizu. 1995. PMID: 8749467 Review. Japanese. No abstract available.